Literature DB >> 32287636

[The diagnosis of sepsis].

L Engelmann1.   

Abstract

The early diagnosis of sepsis is mandatory for the further reduction of mortality due to sepsis. Current findings exist that accentuate the role of the time factor, comparable with acute myocardial infarction or with ischemic stroke. On the other hand, there are no generally accepted diagnostics for sepsis, realizing the demands of early diagnosis and based on the physician's experience.The diagnostics start with the recognition of the inflammatory reaction caused by infection (at least 2 of 4 criteria of inflammatory reaction have to be fulfilled). This definition has high sensitivity, but remarkably lower specificity and it leads either to too frequent admissions or only to hospitalization in case of a complicating organ failure. Making a careful history and knowledge about sepsis are essential for the out-patient department physicians. In addition to the varying pictures of sepsis, the clinicians have laboratory findings available, most of all procalcitonin. Patients have to be considered as septic with a serum PCT level higher than 1 ng/ml particularly when clinical signs do not exclude sepsis and in cases of positive blood cultures. Initially PCT is a product of macrophages if the defense reaction starts, but it becomes an infection marker, when the serum PCT level declines less than the half life falls. © Steinkopff-Verlag 2006.

Entities:  

Keywords:  Sepsis; diagnosis; infection marker; inflammatory response; procalcitonin

Year:  2006        PMID: 32287636      PMCID: PMC7101768          DOI: 10.1007/s00390-006-0741-y

Source DB:  PubMed          Journal:  Intensivmed Notfallmed        ISSN: 0175-3851


  52 in total

1.  Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation.

Authors:  F B Taylor; C H Toh; W K Hoots; H Wada; M Levi
Journal:  Thromb Haemost       Date:  2001-11       Impact factor: 5.249

2.  Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial.

Authors:  Mirjam Christ-Crain; Daiana Jaccard-Stolz; Roland Bingisser; Mikael M Gencay; Peter R Huber; Michael Tamm; Beat Müller
Journal:  Lancet       Date:  2004-02-21       Impact factor: 79.321

3.  Effects of nebulized salbutamol in ARDS.

Authors:  D Benoit; K Vahdewoude; F Colardyn
Journal:  Intensive Care Med       Date:  1998-01       Impact factor: 17.440

4.  Immunological monitoring of the inflammatory process: Which variables? When to assess?

Authors:  H D Volk; P Reinke; W D Döcke
Journal:  Eur J Surg Suppl       Date:  1999

5.  Usefulness of procalcitonin levels in community-acquired pneumonia according to the patients outcome research team pneumonia severity index.

Authors:  Mar Masiá; Félix Gutiérrez; Conrado Shum; Sergio Padilla; Juan Carlos Navarro; Emilio Flores; Ildefonso Hernández
Journal:  Chest       Date:  2005-10       Impact factor: 9.410

6.  Bacteremia and severe sepsis in adults: a multicenter prospective survey in ICUs and wards of 24 hospitals. French Bacteremia-Sepsis Study Group.

Authors:  C Brun-Buisson; F Doyon; J Carlet
Journal:  Am J Respir Crit Care Med       Date:  1996-09       Impact factor: 21.405

Review 7.  Procalcitonin: improved biochemical severity stratification and postoperative monitoring in severe abdominal inflammation and sepsis.

Authors:  B Rau; C M Krüger; M K Schilling
Journal:  Langenbecks Arch Surg       Date:  2004-03-06       Impact factor: 3.445

8.  High serum procalcitonin concentrations in patients with sepsis and infection.

Authors:  M Assicot; D Gendrel; H Carsin; J Raymond; J Guilbaud; C Bohuon
Journal:  Lancet       Date:  1993-02-27       Impact factor: 79.321

9.  High circulating levels of interleukin-6 in patients with septic shock: evolution during sepsis, prognostic value, and interplay with other cytokines. The Swiss-Dutch J5 Immunoglobulin Study Group.

Authors:  T Calandra; J Gerain; D Heumann; J D Baumgartner; M P Glauser
Journal:  Am J Med       Date:  1991-07       Impact factor: 4.965

10.  Procalcitonin kinetics in the prognosis of severe community-acquired pneumonia.

Authors:  Nicolas Boussekey; Olivier Leroy; Serge Alfandari; Patrick Devos; Hugues Georges; Benoit Guery
Journal:  Intensive Care Med       Date:  2006-02-14       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.